Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

ProQR Therapeutics N.V. buy HC Wainwright

Start price
€1.30
07.08.23 / 50%
Target price
€4.55
07.08.24
Performance (%)
25.38%
End price
€1.63
08.08.24
Summary
This prediction ended on 08.08.24 with a price of €1.63. The BUY prediction by HC_Wainwright finished with a performance of 25.38%. HC_Wainwright has a follow-up prediction for ProQR Therapeutics N.V. where he still thinks ProQR Therapeutics N.V. is a Buy. HC_Wainwright has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
ProQR Therapeutics N.V. -4.013% -4.013% 26.078%
iShares Core DAX® 1.743% 1.903% 18.038%
iShares Nasdaq 100 -2.088% -0.640% 25.594%
iShares Nikkei 225® 1.306% 4.161% 16.556%
iShares S&P 500 -0.093% 0.169% 24.312%

Comments by HC_Wainwright for this prediction

In the thread ProQR Therapeutics N.V. diskutieren
Prediction Buy
Perf. (%) 25.38%
Target price 4.546
Change
Ends at 07.08.24

ProQR Therapeutics (NASDAQ: PRQR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat

In the thread Trading ProQR Therapeutics N.V.
Prediction Buy
Perf. (%) 25.38%
Target price 4.546
Change
Ends at 07.08.24

Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten

Current prediction by HC_Wainwright for ProQR Therapeutics N.V.

buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.93
10.05.24
€4.64
10.05.25
-4.71%
26.08.24